Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Vaccine
Sort By
Newest First
1 / 8
1 / 8
GMP
Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur
Intravacc
PR-M03-22-09
March 22, 2022
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06
March 15, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22
January 31, 2022
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
Ocugen, Inc.
PR-M06-21-024
June 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01
June 04, 2021
Vaccine
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Vaxxas
PR-M06-21-006
June 04, 2021
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
Samsung Biologics
PR-M05-21-016
May 25, 2021
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-03
May 17, 2021
Partnership
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
DNA Script
PR-M04-21-029
April 29, 2021
Immunity
The Link Between COVID-19 and Immunity
Dr. Andrew Myers
PTV-04-21-CL-003
April 28, 2021
Manufacturing
Sanofi to Invest in Vaccine Production Site in Singapore
Sanofi
PR-M04-21-011
April 13, 2021
Vaccine
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Valneva SE
PR-M04-21-006
April 08, 2021
COVID-19 Vaccine
UBC Announces Initiative to Accelerate COVID-19 Vaccine Real-World Evidence Generation
UBC
PR-M11-20-046
March 09, 2021
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Rentschler Biopharma
PAP-Q4-20-CL-028
December 09, 2020
COVID-19 Impacts
Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
Pharma's Almanac
PAP-Q4-20-NI-006
December 09, 2020
Vaccine
Cobra Biologics Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate
Cobra Biologics
PR-M11-20-026
December 02, 2020
COVID-19 Vaccine
Russia's Sputnik V COVID-19 Vaccine Is 91% Effective
The Russian Direct Investment Fund (RDIF)
PR-M11-20-023-1178
November 24, 2020
COVID-19 Vaccine
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna
PR-M11-20-013
November 16, 2020
Cancer Vaccine
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
Moderna
PR-M11-20-009
November 11, 2020
Fast Track
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax
PR-M11-20-008
November 10, 2020